Napalkov P, Maisonneuve P, Boyle P
Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy.
Urology. 1995 Sep;46(3 Suppl A):41-6. doi: 10.1016/s0090-4295(99)80249-0.
Benign prostatic hyperplasia (BPH) can be found in 88% of autopsies in men > or = 80 years, with compatible symptomatology reported in nearly 50% of men aged > or = 50 years in the general population. Despite such a common occurrence, little is known with any certainty about the epidemiology of BPH (for which "prostatism" is a commonly, and wrongly, used synonym). Knowledge of risk factors is sparse: analytic epidemiologic studies of BPH are difficult to conduct. It is essential to establish an epidemiologic definition of BPH for these reasons. Both BPH and prostatism are the problems that seem set to increase in absolute terms. They are clearly identified as priority areas for research into their causes and treatment. However, it is clear that there is a great need for more epidemiologic information, particularly regarding prostatism, whose occurrence is unknown in many parts of the world.
在80岁及以上男性的尸检中,88%可发现良性前列腺增生(BPH),在普通人群中,近50%的50岁及以上男性报告有相关症状。尽管BPH如此常见,但对于其流行病学情况(“前列腺增生症”是一个常用但错误的同义词),人们却知之甚少。关于风险因素的了解很少:对BPH进行分析性流行病学研究很困难。出于这些原因,有必要对BPH进行流行病学定义。BPH和前列腺增生症这两个问题的绝对数量似乎都将增加。它们被明确确定为病因和治疗研究的优先领域。然而,显然非常需要更多的流行病学信息,特别是关于前列腺增生症的信息,其在世界许多地区的发病情况尚不清楚。